- Home
- ZKH vs AQST Comparison
ZKH vs AQST Comparison
Compare ZKH & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZKH
- AQST
- Stock Information
- Founded
- ZKH 1998
- AQST 2004
- Country
- ZKH China
- AQST United States
- Employees
- ZKH N/A
- AQST N/A
- Industry
- ZKH
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- ZKH
- AQST Health Care
- Exchange
- ZKH Nasdaq
- AQST Nasdaq
- Market Cap
- ZKH 588.1M
- AQST 502.6M
- IPO Year
- ZKH 2023
- AQST 2018
- Fundamental
- Price
- ZKH $3.60
- AQST $3.60
- Analyst Decision
- ZKH Strong Buy
- AQST Strong Buy
- Analyst Count
- ZKH 2
- AQST 8
- Target Price
- ZKH $12.65
- AQST $10.38
- AVG Volume (30 Days)
- ZKH 45.9K
- AQST 1.5M
- Earning Date
- ZKH 11-22-2024
- AQST 11-04-2024
- Dividend Yield
- ZKH N/A
- AQST N/A
- EPS Growth
- ZKH N/A
- AQST N/A
- EPS
- ZKH N/A
- AQST N/A
- Revenue
- ZKH $1,259,541,805.00
- AQST $58,900,000.00
- Revenue This Year
- ZKH $4.02
- AQST $18.45
- Revenue Next Year
- ZKH $16.24
- AQST N/A
- P/E Ratio
- ZKH N/A
- AQST N/A
- Revenue Growth
- ZKH 3.49
- AQST 22.56
- 52 Week Low
- ZKH $2.62
- AQST $1.84
- 52 Week High
- ZKH $21.91
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- ZKH 41.65
- AQST 36.14
- Support Level
- ZKH $3.37
- AQST $3.56
- Resistance Level
- ZKH $3.75
- AQST $3.92
- Average True Range (ATR)
- ZKH 0.20
- AQST 0.23
- MACD
- ZKH -0.01
- AQST -0.05
- Stochastic Oscillator
- ZKH 21.19
- AQST 13.91
About ZKH ZKH Group Limited each representing thirty-five (35)
ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.